EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report) saw a large increase in short interest in December. As of December 31st, there was short interest totaling 7,240 shares, an increase of 45.5% from the December 15th total of 4,976 shares. Based on an average trading volume of 84,430 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the company’s stock are short sold. Currently, 0.0% of the company’s stock are short sold. Based on an average trading volume of 84,430 shares, the days-to-cover ratio is currently 0.1 days.
Analysts Set New Price Targets
A number of research analysts recently commented on the stock. Hsbc Global Res raised shares of EssilorLuxottica to a “strong-buy” rating in a research report on Wednesday, January 14th. Citigroup restated a “buy” rating on shares of EssilorLuxottica in a report on Thursday, December 11th. Zacks Research downgraded shares of EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 18th. Kepler Capital Markets raised EssilorLuxottica from a “hold” rating to a “buy” rating in a research report on Thursday. Finally, UBS Group upgraded EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a research note on Thursday, November 27th. Two equities research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy”.
Get Our Latest Analysis on ESLOY
EssilorLuxottica Price Performance
About EssilorLuxottica
EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.
The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.
Featured Stories
- Five stocks we like better than EssilorLuxottica
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.
